Cargando…
Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862014/ https://www.ncbi.nlm.nih.gov/pubmed/33549822 http://dx.doi.org/10.1016/j.tmaid.2021.101984 |
| _version_ | 1783647195949432832 |
|---|---|
| author | Honoré, Stéphane Gautret, Philippe |
| author_facet | Honoré, Stéphane Gautret, Philippe |
| author_sort | Honoré, Stéphane |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7862014 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78620142021-02-05 Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients Honoré, Stéphane Gautret, Philippe Travel Med Infect Dis Correspondence Elsevier Ltd. 2021 2021-02-05 /pmc/articles/PMC7862014/ /pubmed/33549822 http://dx.doi.org/10.1016/j.tmaid.2021.101984 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Honoré, Stéphane Gautret, Philippe Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients |
| title | Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients |
| title_full | Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients |
| title_fullStr | Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients |
| title_full_unstemmed | Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients |
| title_short | Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients |
| title_sort | reply to alizazgar j. dangers of the use of hydroxychloroquine and azithromycin combination in covid-19 patients |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862014/ https://www.ncbi.nlm.nih.gov/pubmed/33549822 http://dx.doi.org/10.1016/j.tmaid.2021.101984 |
| work_keys_str_mv | AT honorestephane replytoalizazgarjdangersoftheuseofhydroxychloroquineandazithromycincombinationincovid19patients AT gautretphilippe replytoalizazgarjdangersoftheuseofhydroxychloroquineandazithromycincombinationincovid19patients |